Given that p53 is the most frequently mutated gene in osteosarcoma (OS)26, which arises from osteoblastic lineage cells, defining its role in osteoblast differentiation holds special value to the hunt for etiological and pathogenetic mechanisms underlying OS tumorigenesis and an ultimate cure for OS. This evidence concerns the gene TP53 and osteosarcoma.